Taizhou Power Supply Company Powers Dachen, China’s First Zero-Carbon Island, to Showcase the Future of Clean Energy
The Taizhou Power Supply Company, a subsidiary of State Grid Zhejiang Electric Power Company, is proud to announce the successful transformation of Dachen Island into China’s first zero-carbon island. Dachen is a living demonstration of what a fully green-powered community can look like—from electric cooking and lighting to renewable-powered industries.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250430231800/en/
Tourists on China’s First Zero-Carbon Island, Dachen Island, to experience the sustainable living.
Located 29 nautical miles off the coast of Taizhou in Zhejiang Province, Dachen consists of two islets—Upper and Lower Dachen. Though the island is a two-hour boat ride from the mainland, it’s at the forefront of China’s green energy transformation.
Once a test site for early wind turbines, Dachen now operates some of the world’s most advanced energy technologies, including a pioneering 20 Hz flexible low-frequency power transmission system—an international first.
“This system reduces the charging power demand of submarine cables, lowers investment costs, and stabilizes the grid,” said Zhang Ye, Deputy Director at State Grid Zhejiang Taizhou Power Supply Company. “It’s a key breakthrough for long-distance offshore wind transmission.”
The island’s journey from energy scarcity to surplus is just as compelling. In the past, Dachen relied on diesel generators, going dark at night. That began to change in 2009, when it shifted to wind energy. Today, Dachen generates over 60 million kilowatt-hours of clean electricity annually—six times its own needs—with the excess sent back to the mainland.
Three retired turbine blades now stand outside the island’s power station as quiet symbols of that transformation. “We’re not just carbon-neutral—we’re power exporters,” said Jiang Weijian, director of the station.
This energy shift is benefiting local industries. The island’s signature yellow croaker fish is now farmed with electric-powered systems, replacing diesel and reducing costs and emissions. Tourism has also surged, with visitors drawn to Dachen’s electric homestays, green transport, and fully renewable infrastructure.
Dachen’s transformation underscores Taizhou Power Supply Company’s leadership in clean energy innovation. From its offshore turbines to its pioneering grid technology, Dachen Island is a beacon for China’s clean energy ambitions—proving that a net-zero future is not a distant dream, but a working reality.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250430231800/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
MAG Signs Strategic Partnership with MultiBank Group to Tokenize $3 Billion Real Estate Assets1.5.2025 16:30:00 CEST | Press release
MAG, the leading real estate developer in the UAE has signed a historic $3 billion tokenization agreement with MultiBank Group, the world’s largest financial derivatives institution based in Dubai, and Mavryk, a leading blockchain innovator — marking the largest real-world asset (RWA) tokenization initiative globally to date. The initiative highlights the imminent launch of $MBG, the utility token at the core of MultiBank’s next-generation digital finance ecosystem. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250501021414/en/ The Ritz-Carlton Residences, Dubai, Creekside at the Keturah Resort (Photo: AETOSWire) The partnership will bring MAG’s high-value real estate developments — The Ritz-Carlton Residences, Dubai, Creekside, part of the Keturah Resort, and Keturah Reserve — onto the blockchain, making them available to global investors via MultiBank.io’s fully regulated RWA marketplace. Once launched, holders of the RWA
Part of $1 Billion Investment Strategy, PCI Pharma Services Completes Acquisition of Ajinomoto Althea, Enhancing US Drug Product Manufacturing for Aseptic Filling of Prefilled Syringes & Cartridges1.5.2025 16:00:00 CEST | Press release
Along with PCI’s own robust infrastructure expansions, acquisition furthers CDMO’s recent growth in sterile fill-finish, advanced drug delivery systems like prefilled syringes and cartridges, and biologics – including high potent assets for antibody-drug conjugates. PCI Pharma Services (“PCI”) – a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies – has completed its acquisition of Ajinomoto Althea, Inc. (“Althea”), a US-based sterile fill-finish CDMO and subsidiary of Japan-based Ajinomoto Co., Inc. For PCI, the acquisition is a cornerstone of a multi-year investment strategy spanning facilities in the United States and Europe. In the United States, Althea’s assets combine with PCI’s existing sterile fill-finish and advanced drug delivery operations to form a world-class, large-scale manufacturing hub in San Diego, complete with state-of-the-art large-scale aseptic facilities for prefilled syringes and cartridges. Among
Boomi Launches DataHub Command Center, Powered by ServiceNow, Enabling Organizations to Unlock the Full Potential of Their Data1.5.2025 15:00:00 CEST | Press release
Boomi™, the intelligent integration and automation leader, today announced the general availability of Boomi DataHub Command Center, a new module within Boomi DataHub that unifies data from disparate sources, simplifies governance, and promotes actionable insights. Powered by the enterprise-grade workflows on the ServiceNow® Platform and managed entirely by Boomi, Boomi DataHub Command Center empowers organizations to unlock the full potential of their data through interactive visualization, robust traceability, and historical analysis. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250501619915/en/ Boomi Launches DataHub Command Center, Powered by ServiceNow, Enabling Organizations to Unlock the Full Potential of Their Data Modern businesses are increasingly challenged by disconnected data systems, unclear data lineage, and insufficient oversight—barriers that stifle growth and innovation. According to Forrester, global dat
Harini Gopalakrishnan Joins Vespa.ai as General Manager of Health & Life Sciences1.5.2025 15:00:00 CEST | Press release
Former Global CTO for Life Sciences at Snowflake to Lead Vespa’s Expansion into the Sector Vespa.ai, the platform for large-scale, real-time AI applications powered by big data, today announced the appointment of Harini Gopalakrishnan as General Manager of Health & Life Sciences. Gopalakrishnan, formerly Global CTO for Life Sciences at Snowflake, will spearhead Vespa’s strategic initiatives in the sector. Vespa.ai provides the infrastructure to build and deploy AI-driven applications for search and retrieval-augmented generation (RAG), offering precise, real-time access to large language models (LLMs). In Health and Life Sciences, this capability enables teams to search, connect, and extract insight from complex multimodal data, accelerating research, clinical decision-making, and commercial innovation. Harini Gopalakrishnan, GM Health & Life Sciences, Vespa.ai: “AI’s success in life sciences depends on unlocking insights across vast data, where one navigates a complex ecosystem of mul
Crown Bioscience and NEXT Oncology Cement Partnership Extension1.5.2025 14:30:00 CEST | Press release
Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life Sciences and Japan-based JSR Corporation, is pleased to announce the extension of its partnership with NEXT Oncology, one of the world’s largest Phase I Oncology Clinical Trial networks. This strategic partnership will continue to leverage Crown Bioscience's extensive experience in developing clinically relevant cancer organoid and patient-derived xenograft (PDX) models, together with NEXT Oncology's global clinical network and Phase I clinical trials expertise. Through this extended agreement, Crown Bioscience reaffirms its exclusive rights to provide services based on patient samples sourced from NEXT Oncology’s industry-leading global clinical trial network. This collaboration underscores Crown Bioscience's commitment to providing the most clinically relevant PDX and organoid models and solutions for translational oncology research. "We are thrilled to continue our
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom